| Reaction Details |
|---|
 | Report a problem with these data |
| Target | Coagulation factor VII |
|---|
| Ligand | BDBM14599 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | ChEBML_48465 |
|---|
| IC50 | 14700±n/a nM |
|---|
| Citation |  Parlow, JJ; Kurumbail, RG; Stegeman, RA; Stevens, AM; Stallings, WC; South, MS Synthesis and X-ray crystal structures of substituted fluorobenzene and benzoquinone inhibitors of the tissue factor VIIa complex. Bioorg Med Chem Lett13:3721-5 (2003) [PubMed] |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| Coagulation factor VII |
|---|
| Name: | Coagulation factor VII |
|---|
| Synonyms: | Eptacog alfa | F7 | FA7_HUMAN | Factor VIIa | Factor VIIa (fVIIa) | Proconvertin | SPCA | Thrombin and coagulation factor VII | serum prothrombin conversion accelerator |
|---|
| Type: | Enzyme |
|---|
| Mol. Mass.: | 51599.89 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | n/a |
|---|
| Residue: | 466 |
|---|
| Sequence: | MVSQALRLLCLLLGLQGCLAAGGVAKASGGETRDMPWKPGPHRVFVTQEEAHGVLHRRRR
ANAFLEELRPGSLERECKEEQCSFEEAREIFKDAERTKLFWISYSDGDQCASSPCQNGGS
CKDQLQSYICFCLPAFEGRNCETHKDDQLICVNENGGCEQYCSDHTGTKRSCRCHEGYSL
LADGVSCTPTVEYPCGKIPILEKRNASKPQGRIVGGKVCPKGECPWQVLLLVNGAQLCGG
TLINTIWVVSAAHCFDKIKNWRNLIAVLGEHDLSEHDGDEQSRRVAQVIIPSTYVPGTTN
HDIALLRLHQPVVLTDHVVPLCLPERTFSERTLAFVRFSLVSGWGQLLDRGATALELMVL
NVPRLMTQDCLQQSRKVGDSPNITEYMFCAGYSDGSKDSCKGDSGGPHATHYRGTWYLTG
IVSWGQGCATVGHFGVYTRVSQYIEWLQKLMRSEPRPGVLLRAPFP
|
|
|
|---|
| BDBM14599 |
|---|
| n/a |
|---|
| Name | BDBM14599 |
|---|
| Synonyms: | CHEMBL333980 | N-[(4-carbamimidoylphenyl)methyl]-2-[2-methoxy-6-phenyl-3-(propan-2-ylamino)phenyl]acetamide | N-{4-[Amino(imino)methyl]benzyl}-2-[4-(isopropylamino)-3-methoxy-1,1-biphenyl-2-yl]acetamide | Substituted Benzene Analog 50e |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C26H30N4O2 |
|---|
| Mol. Mass. | 430.542 |
|---|
| SMILES | COc1c(NC(C)C)ccc(-c2ccccc2)c1CC(=O)NCc1ccc(cc1)C(N)=N |
|---|
| Structure | 
|
|---|
Search and Browse
